Wockhardt gets tentative USFDA nod for anti-psychotic drugPharmaceutical firm Wockhardt today said it has received tentative approval from US health regulator for its generic version of anti-psycho...
22 Aug, 2012, 04.34 PM IST
- Brokerages maintain 'hold' on Dr Reddy's post results
Shares of Dr Reddy’s Laboratories (DRL) were down on profit booking after the company disappointed the street with its quarterly results ye...
20 Jul, 2012, 01.30 PM IST
- Unfair practices: Pharma cos GlaxoSmithkline, Pfizer, Johnson & Johnson and others fined $13 bn in 4 years
GlaxoSmithkline, Pfizer, Johnson & Johnson, AstraZeneca, Merck, Abbot, Eli Lilly and Allergen have paid about $13 billion in fines to settl...
16 Jul, 2012, 01.05 PM IST
- Why Dr Reddy's labs is going to report good results
The Hyderabad-based company with FY12 net sales Rs 9674 crore is expected to report good results to the cheer of its investors.
13 Jul, 2012, 03.39 PM IST
- Indian drug outlook favourable: ICRA & Moody's
According to the report, domestic formulation market size stood at Rs 58,300 crore, ranked third in terms of volume and tenth in terms of v...
20 Jun, 2012, 06.52 PM IST
- Dr Reddy's Q4 net profit seen at Rs 448cr, up 34% YoY
Dr Reddy's Laboratories is expected to report a 34% YoY increase in net profit to Rs 448 crore for the fourth quarter, according to an ET N...
11 May, 2012, 10.01 AM IST
- Lupin Q4 net profit seen up 16% at Rs 263 crore
Lupin is expected to report a 16 percent YoY increase in its fourth quarter net profit at Rs 263 crore from Rs 227 crore in the year-ago pe...
10 May, 2012, 10.46 AM IST
- Brokers' Call: ONGC, DRL, Cipla and Coal India
We have compiled stock views and recommendations from various agencies on ONGC, Dr Reddy's, Cipla and Coal India.
06 Mar, 2012, 10.36 AM IST
- Dr Reddy's Lab can Touch 1,950: HSBC
HSBC has reiterated its 'Overweight' rating on Dr Reddy's Lab and set a target price of 1,950.
06 Mar, 2012, 05.18 AM IST
- Dr Reddy's launches Ziprasidone Hydrochloride capsules in US
Dr Reddy's Laboratories announced today that it has launched Ziprasidone Hydrochloride Capsules, a bioequivalent generic version of Geodon,...
03 Mar, 2012, 05.31 PM IST
- Dr Reddy's launches generic version of Pfizer's Geodon capsules in US market
Dr Reddy's Lab said it has launched a generic version of Pfizer's Geodon capsules in the US market, used in treating mental disorders.
03 Mar, 2012, 02.42 PM IST
- Hedged all forex exposure for short term: S Ramesh, CFO, Lupin
In an interview with ET Now, S Ramesh, CFO, Lupin, talks about pharma and company's strategies.
27 Dec, 2011, 02.18 PM IST
- Looking at acquisitions in Latin Ameican market: S Ramesh, Lupin Ltd.
S Ramesh, President Finance and Planning, Lupin Ltd. in an interview with ET Now talks about the expected growth from the US market and the...
15 Jun, 2011, 04.24 PM IST
- Pfizer faces US probe, to pay $2.3 bn
Pfizer will pay $2.3 bn to settle a US investigation into illegal marketing of medicines, the largest agreement in such a case, and a subsi...
03 Sep, 2009, 02.21 AM IST
- Children's disorders increases sales of US pharma cos
Sales for children of antipsychotic medicines have exploded, fuelled by a 40-fold increase over nine years in the number of children diagno...
07 Sep, 2007, 02.08 AM IST
- Lupin receives USFDA nod for anti-psychotic drug
Domestic pharma company Lupin Ltd on Monday said it has received tentative approval from the US Food and Drug Administration (USFDA) for it...
21 May, 2007, 02.30 PM IST
- Pfizer Q3 profit doubles to $3.4bn
Pfizer on Thursday said third-quarter earnings doubled from the year-ago quarter when it took a big merger-related charge, helped by strong...
21 Oct, 2006, 12.45 AM IST